Innovation Pharmaceuticals Inc (IPIX)

[Ultimate01]

I'm sharing my notes from the R&R webcast in hopes that others will too and we increase our knowledge base.

GO CTIX!!!


1. Kevetrin
a. Starting 350mg/m² week of September 8th; CA-125 had 7 dosing cycles; Grade 2 Erythemia easily treated with pre-medication; no grade 2 SAEs in 8th cohort should result in faster progression; 3 September, University of Bologna study received ethics approval
2. Brillacidin
a. Cure rate at 7 days higher than Daptomyacin; 75% of study Brillacidin; B-OM IND submitted for phase II; Toxicology report received last month (August sometime);Awaiting to meet with FDA to develop Diabetic Foot Pathway
3. CTIX 1502
a. Single Topical Application against Candida; “Superior to other anti-fungals”; Little cytotoxicity; Unmet Medical Need
4. Prurisol
a. “Great unmet medical need”; Submitted request to meet with FDA for a pase II/III plan
5. Delparantag
a. Treatment for COPD with dosing modification; “Mouthwatering”